Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study.
Jones RW, Sadler L, Grant S, Whineray J, Exeter M, Rowan D.
J Reprod Med. 2004 Oct;49(10):808-11.
PMID:15568404
Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma.
Renaud-Vilmer C, Cavelier-Balloy B, Verola O, Morel P, Servant JM, Desgrandchamps F, Dubertret L.
J Am Acad Dermatol. 2010 Feb;62(2):284-90. doi: 10.1016/j.jaad.2009.06.087.
PMID:20115951
Squamous cell carcinoma of the vulva in association with mixed vulvar dystrophy. A brief report with review of literature.
Kini U.
Indian J Cancer. 1997 Jun;34(2):92-5.
PMID:9491669
Hypertrophic lichen sclerosus with dyskeratosis and parakeratosis--a common presentation of vulvar lichen sclerosus not associated with a significant risk of malignancy.
Weyers W.
Am J Dermatopathol. 2013 Oct;35(7):713-21. doi: 10.1097/DAD.0b013e31827e7ea9.
PMID:23328790
Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma.
Hart WR, Norris HJ, Helwig EB.
Obstet Gynecol. 1975 Apr;45(4):369-77.
PMID:1091897
TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva.
Rolfe KJ, MacLean AB, Crow JC, Benjamin E, Reid WM, Perrett CW.
Br J Cancer. 2003 Dec 15;89(12):2249-53. doi: 10.1038/sj.bjc.6601444.
PMID:14676802
Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus.